CN Patent

CN1886119A — 泮托拉唑多颗粒制剂

Assigned to Co Nicomede Asset Management Co · Expires 2006-12-27 · 19y expired

What this patent protects

本文描述了泮托拉唑钠多颗粒，它避免粘着在鼻饲管和胃管上。泮托拉唑多颗粒具有泮托拉唑或其对映体或其盐、表面活性剂和崩解剂的球形核；由羟丙基甲基纤维素(羟丙甲纤维素)和水组成的底衣，底衣上的肠溶衣，和肠溶衣上的最后隔离层，其由羟丙基甲基纤维素(羟丙甲纤维素)和水组成。

USPTO Abstract

本文描述了泮托拉唑钠多颗粒，它避免粘着在鼻饲管和胃管上。泮托拉唑多颗粒具有泮托拉唑或其对映体或其盐、表面活性剂和崩解剂的球形核；由羟丙基甲基纤维素(羟丙甲纤维素)和水组成的底衣，底衣上的肠溶衣，和肠溶衣上的最后隔离层，其由羟丙基甲基纤维素(羟丙甲纤维素)和水组成。

Drugs covered by this patent

Pantoprazole Sodium (Pantoprazole Sodium) · Pfizer

Patent Metadata

Patent number: CN1886119A
Jurisdiction: CN
Classification: —
Expires: 2006-12-27
Drug substance claim: No
Drug product claim: No
Assignee: Co Nicomede Asset Management Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.